BioNano Genomics Cash Conversion Cycle 2011-2026 | BNGO

Annual Cash Conversion Cycle BioNano Genomics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
166	225	319	236	104	144	268	125	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
319	104	198

Quarterly Cash Conversion Cycle BioNano Genomics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
124	171	202	-	156	335	331	-	348	348	380	-	169	123	200	-	87	94.4	94.7	-	139	273	426	247	203	309	285	94	137	107	155	70.3	39.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
426	39.3	202

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Medpace Holdings MEDP	50.4	$ 464.9	0.9 %	$ 13.4 B	USA
Biodesix BDSX	41.7	$ 15.0	-3.47 %	$ 1.95 B	USA
Biomerica BMRA	172	$ 2.13	-1.54 %	$ 4.89 M	USA
Bioventus BVS	224	$ 9.26	1.15 %	$ 617 M	USA
DexCom DXCM	134	$ 66.59	-0.02 %	$ 26 B	USA
Mettler-Toledo International MTD	66.4	$ 1 269.13	0.28 %	$ 26.2 B	Schweiz
Neogen Corporation NEOG	150	$ 9.33	2.41 %	$ 2.02 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Guardant Health GH	79.6	$ 85.95	2.82 %	$ 10.8 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
National Research Corporation NRC	29.4	$ 17.39	-0.29 %	$ 389 M	USA
Natera NTRA	81.5	$ 198.9	2.25 %	$ 19.6 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	185	$ 1.41	1.08 %	$ 423 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-38.7	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	299	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Precipio PRPO	-3.19	$ 29.06	9.25 %	$ 37.7 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
RadNet RDNT	34.5	$ 60.99	1.87 %	$ 4.59 B	USA
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	65	$ 163.49	2.68 %	$ 8.1 B	USA
IQVIA Holdings IQV	73.9	$ 166.64	0.3 %	$ 28.6 B	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA
Myriad Genetics MYGN	49.3	$ 4.71	2.17 %	$ 436 M	USA
Senseonics Holdings SENS	36.1	$ 6.75	1.35 %	$ 282 M	USA
Sotera Health Company SHC	33.5	$ 13.89	0.36 %	$ 3.94 B	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Soleno Therapeutics SLNO	-398	$ 32.6	4.02 %	$ 1.66 B	USA
Interpace Biosciences IDXG	44.9	$ 1.71	-	$ 7.5 M	USA
Neuronetics STIM	17.3	$ 1.41	-3.09 %	$ 93 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Personalis PSNL	-11.5	$ 8.15	4.69 %	$ 483 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	40.3	$ 266.8	0.25 %	$ 22.2 B	USA
ENDRA Life Sciences NDRA	-1.24 K	$ 3.5	1.2 %	$ 1.88 M	USA
NeoGenomics NEO	82.4	$ 7.93	0.89 %	$ 1.02 B	USA
Thermo Fisher Scientific TMO	70	$ 490.67	0.13 %	$ 185 B	USA